Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Heinz Subsidiary Signs Infant Formula License Agreement With Martek - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Heinz Subsidiary Signs Infant Formula License Agreement With Martek

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Heinz Subsidiary Signs Infant Formula License Agreement With Martek
Columbia, MD-based Martek Biosciences Corporation has signed a non exclusive agreement with Heinz Wattie’s Limited, Hastings, New Zealand, for Martek’s technology relating to the use of long chain polyunsaturated fatty acids in infant formula. The agreement provides for initial cash payments and would give Martek an ongoing royalty upon Heinz’s introduction of products using Martek’s technology for doco­sahexaenoic acid (DHA) and arachidonic acid (ARA). The license covers Australia, New Zealand and certain Pacific island

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics